No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr20:23618600-23624800 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
2 |
chr20:23618600-23626000 |
Weak transcription |
Gastric |
stomach
|
3 |
chr20:23618800-23625200 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
4 |
chr20:23618800-23626400 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|
5 |
chr20:23618800-23628600 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
6 |
chr20:23620000-23625000 |
Enhancers |
Fetal Thymus |
thymus
|
7 |
chr20:23621200-23625200 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
8 |
chr20:23621400-23624800 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
9 |
chr20:23621400-23625000 |
Enhancers |
Adipose Nuclei |
Adipose
|
10 |
chr20:23621800-23624600 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
11 |
chr20:23622000-23625600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
12 |
chr20:23622200-23624800 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
13 |
chr20:23622200-23636600 |
Weak transcription |
Pancreas |
Pancrea
|
14 |
chr20:23622800-23625400 |
Weak transcription |
H1 Cell Line |
embryonic stem cell
|
15 |
chr20:23622800-23625400 |
Weak transcription |
H9 Cell Line |
embryonic stem cell
|
16 |
chr20:23622800-23640000 |
Weak transcription |
Stomach Mucosa |
stomach
|
17 |
chr20:23623000-23624800 |
Weak transcription |
Duodenum Mucosa |
Duodenum
|
18 |
chr20:23623000-23625200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
19 |
chr20:23623000-23634200 |
Weak transcription |
Right Atrium |
heart
|
20 |
chr20:23623200-23626800 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
21 |
chr20:23623200-23636200 |
Weak transcription |
Lung |
lung
|
22 |
chr20:23623400-23625000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
23 |
chr20:23623400-23625400 |
Weak transcription |
Brain Dorsolateral Prefrontal Cortex |
brain
|
24 |
chr20:23623400-23625600 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
25 |
chr20:23623600-23626800 |
Weak transcription |
NHEK |
skin
|
26 |
chr20:23623600-23627200 |
Weak transcription |
HMEC |
breast
|
27 |
chr20:23623800-23624800 |
Weak transcription |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
28 |
chr20:23623800-23625000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
29 |
chr20:23623800-23626600 |
Weak transcription |
HUVEC |
blood vessel
|
30 |
chr20:23623800-23627000 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
31 |
chr20:23624000-23624600 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
32 |
chr20:23624000-23624800 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
33 |
chr20:23624200-23624800 |
Enhancers |
Primary B cells from cord blood |
blood
|
34 |
chr20:23624200-23633000 |
Weak transcription |
Duodenum Smooth Muscle |
Duodenum
|
35 |
chr20:23624400-23624600 |
Enhancers |
Thymus |
Thymus
|
36 |
chr20:23624400-23624600 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
37 |
chr20:23624400-23625000 |
Flanking Active TSS |
GM12878-XiMat |
blood
|
38 |
chr20:23624400-23626600 |
Weak transcription |
Fetal Muscle Leg |
muscle
|
39 |
chr20:23624400-23627400 |
Weak transcription |
HepG2 |
liver
|